New study shows that common genetic variation among people is responsible for mediating SARS-CoV-2 asymptomatic infection.
Have you ever wondered why some people never became sick from COVID-19? A study published recently in the journal Nature shows that common genetic variation among people is responsible for mediating SARS-CoV-2 asymptomatic infection. The results indicate that individuals having this variant never feel sick once infected. This exciting discovery was a result of a U.S.-Australia collaborative work led by Danillo Augusto, Ph.D., assistant professor at the University of North Carolina at Charlotte; Jill Hollenbach, Ph.D., professor at the University of California San Francisco; and Stephanie Gras, professor at La Trobe University in Australia.
The Role of Human Leukocyte Antigens (HLA)
The study focuses on a group of genes called human leukocyte antigens (HLA). These HLA genes code for proteins used by the immune system to identify your healthy cells and distinguish them from those infected by bacteria and viruses. The HLA system is critical for immune response and also highly variable among individuals. Because of the role of HLAs in fighting infection, the researchers wondered if there were specific variants that would make us more protected or susceptible to SARS-CoV-2 virus.
Danillo Augusto, assistant professor of Biological Sciences at UNC Charlotte. Credit: UNC Charlotte
Research Findings and Methodology
Hollenbach led the data collection, which started at the beginning of the pandemic. First, 29,947 unvaccinated individuals were screened using a mobile app designed specifically to track COVID-19 symptoms, and 1,428 reported a positive test for the virus. All individuals had their DNA previously sequenced to analyze their HLA genes. The researchers found that individuals having the genetic variant HLA-B*15:01 were much more likely to remain asymptomatic after infection. Impressively, this variant is present in about 10% of the population. In summary, individuals who had HLA-B*1501 in their genome could not dodge the infection, however, they escaped being sick.
Insights on Immune Response
"We hypothesized that their immune system could react so fast and powerfully that the virus was eliminated before causing any symptoms. It's like having an army that already knows what to look for and can tell by the uniform that these are the bad guys," according to Hollenbach.
HLA molecules display pieces of the virus to immune effector cells for inspection. The study used cells from individuals with HLA-B*15:01 who donated blood several years before the pandemic. The results showed that those individuals had memory T cells against a specific particle of SARS-CoV-2. Individuals who never had any contact with SARS-CoV-2 had already had some kind of previous exposure to other viruses and developed immunological memory against a particle from SARS-CoV-2.
Their immunological memory would elicit a much faster response and explain why those individuals remained asymptomatic. Still, it remained intriguing how they could develop immunological memory against SARS-CoV-2 without ever being exposed to this virus.
Cross-Reactive Immunological Responses
"It is widely known that other types of coronaviruses have caused seasonal colds for decades. We hypothesized that these individuals were exposed to seasonal coronaviruses in the past, and somehow, individuals specifically carrying HLA-B*15:01 could quickly kill cells infected by SARS-CoV-2 due to cross-reactive immunological responses. So, even if the bad guys changed the uniform, the army would still be able to identify them by their boots or maybe a tattoo on their arms. That is how our immunological memory works to keep us healthy," said Augusto.
After carefully analyzing the genomic sequences of all coronaviruses, the study showed that this SARS-CoV-2 particle recognized by HLA-B*15:01 in unexposed individuals is very similar to viral particles from other previous coronaviruses. The research demonstrated that T cells from pre-pandemic individuals could identify viral particles from past coronaviruses and SARS-CoV-2 with the same efficiency by showing crystal structures and affinity assays. It means those individuals created immunological memory for the previous coronaviruses, but because of the high similarity of this viral particle, their memory T cells can also recognize and kill SARS-CoV-2 very fast.
Implications and Future Research
The results show a mechanism for how individuals can avoid being sick from SARS-CoV-2 and the research group plans to continue learning about the response against this virus, which will result in better understanding of COVID-19 therapeutics and vaccines.
For more on this research, see Unmasking the Secret of COVID-19 "Super Dodgers."
Reference: "A common allele of HLA is associated with asymptomatic SARS-CoV-2 infection" by Danillo G. Augusto, Lawton D. Murdolo, Demetra S. M. Chatzileontiadou, Joseph J. Sabatino Jr, Tasneem Yusufali, Noah D. Peyser, Xochitl Butcher, Kerry Kizer, Karoline Guthrie, Victoria W. Murray, Vivian Pae, Sannidhi Sarvadhavabhatla, Fiona Beltran, Gurjot S. Gill, Kara L. Lynch, Cassandra Yun, Colin T. Maguire, Michael J. Peluso, Rebecca Hoh, Timothy J. Henrich, Steven G. Deeks, Michelle Davidson, Scott Lu, Sarah A. Goldberg, J. Daniel Kelly, Jeffrey N. Martin, Cynthia A. Vierra-Green, Stephen R. Spellman, David J. Langton, Michael J. Dewar-Oldis, Corey Smith, Peter J. Barnard, Sulggi Lee, Gregory M. Marcus, Jeffrey E. Olgin, Mark J. Pletcher, Martin Maiers, Stephanie Gras and Jill A. Hollenbach, 19 July 2023, Nature.
DOI: 10.1038/s41586-023-06331-x
News
This Viral RNA Structure Could Lead to a Universal Antiviral Drug
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for enteroviruses. A new study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, explains how enteroviruses begin reproducing [...]
New study suggests a way to rejuvenate the immune system
Stimulating the liver to produce some of the signals of the thymus can reverse age-related declines in T-cell populations and enhance response to vaccination. As people age, their immune system function declines. T cell [...]
Nerve Damage Can Disrupt Immunity Across the Entire Body
A single nerve injury can quietly reshape the immune system across the entire body. Preclinical research from McGill University suggests that nerve injuries may lead to long-lasting changes in the immune system, and these [...]
Fake Science Is Growing Faster Than Legitimate Research, New Study Warns
New research reveals organized networks linking paper mills, intermediaries, and compromised academic journals Organized scientific fraud is becoming increasingly common, ranging from fabricated research to the buying and selling of authorship and citations, according [...]
Scientists Unlock a New Way to Hear the Brain’s Hidden Language
Scientists can finally hear the brain’s quietest messages—unlocking the hidden code behind how neurons think, decide, and remember. Scientists have created a new protein that can capture the incoming chemical signals received by brain [...]
Does being infected or vaccinated first influence COVID-19 immunity?
A new study analyzing the immune response to COVID-19 in a Catalan cohort of health workers sheds light on an important question: does it matter whether a person was first infected or first vaccinated? [...]
We May Never Know if AI Is Conscious, Says Cambridge Philosopher
As claims about conscious AI grow louder, a Cambridge philosopher argues that we lack the evidence to know whether machines can truly be conscious, let alone morally significant. A philosopher at the University of [...]
AI Helped Scientists Stop a Virus With One Tiny Change
Using AI, researchers identified one tiny molecular interaction that viruses need to infect cells. Disrupting it stopped the virus before infection could begin. Washington State University scientists have uncovered a method to interfere with a key [...]
Deadly Hospital Fungus May Finally Have a Weakness
A deadly, drug-resistant hospital fungus may finally have a weakness—and scientists think they’ve found it. Researchers have identified a genetic process that could open the door to new treatments for a dangerous fungal infection [...]
Fever-Proof Bird Flu Variant Could Fuel the Next Pandemic
Bird flu viruses present a significant risk to humans because they can continue replicating at temperatures higher than a typical fever. Fever is one of the body’s main tools for slowing or stopping viral [...]
What could the future of nanoscience look like?
Society has a lot to thank for nanoscience. From improved health monitoring to reducing the size of electronics, scientists’ ability to delve deeper and better understand chemistry at the nanoscale has opened up numerous [...]
Scientists Melt Cancer’s Hidden “Power Hubs” and Stop Tumor Growth
Researchers discovered that in a rare kidney cancer, RNA builds droplet-like hubs that act as growth control centers inside tumor cells. By engineering a molecular switch to dissolve these hubs, they were able to halt cancer [...]
Platelet-inspired nanoparticles could improve treatment of inflammatory diseases
Scientists have developed platelet-inspired nanoparticles that deliver anti-inflammatory drugs directly to brain-computer interface implants, doubling their effectiveness. Scientists have found a way to improve the performance of brain-computer interface (BCI) electrodes by delivering anti-inflammatory drugs directly [...]
After 150 years, a new chapter in cancer therapy is finally beginning
For decades, researchers have been looking for ways to destroy cancer cells in a targeted manner without further weakening the body. But for many patients whose immune system is severely impaired by chemotherapy or radiation, [...]
Older chemical libraries show promise for fighting resistant strains of COVID-19 virus
SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid. Now, University of California San Diego scientists and an international team of [...]
Lower doses of immunotherapy for skin cancer give better results, study suggests
According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects. This is reported by researchers at Karolinska Institutet in the Journal of the National [...]
